Literature DB >> 22553583

Chronic macular edema associated with extrafoveal vitreoretinal traction.

Aaron Trevino1, Michael R Martinez, Avinoam Ophir.   

Abstract

AIM: To describe an association between extrafoveal vitreoretinal traction and chronic macular edema, either diffuse (DiME) or cystoid (CME), by the use of optical coherence tomography (OCT).
METHODS: Charts and OCT findings of two patients with persistent DiME or persistent DiME accompanied by CME, both associated with extrafoveal vitreous traction membranes were analyzed. Excluded were eyes that either had another vitreoretinopathy that could affect the analysis, had undergone pars plana vitrectomy or that had been treated by intravitreal medications. An age-matched normal control group for OCT (n=12) allowed for the quantification of the normal macular thicknesses.
RESULTS: One patient (one eye) following perforating ocular injury and one patient (one eye) of idiopathic origin, both with chronic macular edema refractive to conventional treatment, were found to be associated with extrafoveal vitreoretinal traction in each eye. Retinal edema that was underlying the traction site in each eye was in continuum with the central macular edema, thus manifesting as diffuse macular edema. The automatic central 6-radial lines program in the OCT enabled the detection of the traction site in one eye, while in the other eye the diagnosis was achieved only with the additional use of the Line group program.
CONCLUSION: Chronic diffuse macular edema might be related to extrafoveal vitreoretinal traction. Careful search with the diverse OCT programs should be made in order to detect extrafoveal traction sites. Further studies and a larger cohort are required to compare the efficacy of early vitrectomy or pharmacologic vitreolysis versus the current therapeutic approaches in these situations.

Entities:  

Keywords:  extrafoveal vitreous traction; macular edema; ocular perforation; optical coherence tomography

Year:  2010        PMID: 22553583      PMCID: PMC3340744          DOI: 10.3980/j.issn.2222-3959.2010.04.10

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  19 in total

Review 1.  Macular oedema: the role of soluble mediators.

Authors:  D Kent; S A Vinores; P A Campochiaro
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

2.  Comparison of retinal thickness measurements between three-dimensional and radial scans on spectral-domain optical coherence tomography.

Authors:  Kaori Sayanagi; Sumit Sharma; Peter K Kaiser
Journal:  Am J Ophthalmol       Date:  2009-06-03       Impact factor: 5.258

3.  Characterization of macular edema from various etiologies by optical coherence tomography.

Authors:  Antoine Catier; Ramin Tadayoni; Michel Paques; Ali Erginay; Belkacem Haouchine; Alain Gaudric; Pascale Massin
Journal:  Am J Ophthalmol       Date:  2005-08       Impact factor: 5.258

4.  Intravitreal injection of microplasmin for treatment of vitreomacular adhesion: results of a prospective, randomized, sham-controlled phase II trial (the MIVI-IIT trial).

Authors:  Peter Stalmans; Christophe Delaey; Marc D de Smet; Edith van Dijkman; Steve Pakola
Journal:  Retina       Date:  2010 Jul-Aug       Impact factor: 4.256

Review 5.  Prostaglandins and cystoid macular edema.

Authors:  Kensaku Miyake; Nobuhiro Ibaraki
Journal:  Surv Ophthalmol       Date:  2002-08       Impact factor: 6.048

6.  Non-diabetic diffuse macular edema associated with extrafoveal vitreous traction.

Authors:  Samia Fatum; Aaron Trevino; Avinoam Ophir
Journal:  Isr Med Assoc J       Date:  2009-05       Impact factor: 0.892

7.  Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy.

Authors:  J F Arevalo; M Maia; H W Flynn; M Saravia; R L Avery; L Wu; M Eid Farah; D J Pieramici; M H Berrocal; J G Sanchez
Journal:  Br J Ophthalmol       Date:  2007-10-26       Impact factor: 4.638

8.  Successful treatment of cystoid macular edema with valdecoxib.

Authors:  Alexander Reis; Florian Birnbaum; Lutz L Hansen; Thomas Reinhard
Journal:  J Cataract Refract Surg       Date:  2007-04       Impact factor: 3.351

9.  Treatment of acute pseudophakic cystoid macular edema: Diclofenac versus ketorolac.

Authors:  David S Rho
Journal:  J Cataract Refract Surg       Date:  2003-12       Impact factor: 3.351

10.  Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results.

Authors:  J Fernando Arevalo; Mauricio Maia; Rafael A Garcia-Amaris; Jose A Roca; Juan G Sanchez; Maria H Berrocal; Lihteh Wu
Journal:  Ophthalmology       Date:  2009-07-09       Impact factor: 12.079

View more
  2 in total

1.  Enzymatic vitreolysis for the treatment of tractional diabetic macular edema.

Authors:  Bernardete Pessoa; João Coelho; Constança Coelho; Sílvia Monteiro; Carolina Abreu; João Figueira; Angelina Meireles; João Nuno Melo Beirão
Journal:  Ther Adv Ophthalmol       Date:  2019-08-22

2.  Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis.

Authors:  Bernardete Pessoa; Luísa Malheiro; Inês Carneiro; Sílvia Monteiro; João Coelho; Constança Coelho; João Figueira; Angelina Meireles; João Nuno Melo Beirão
Journal:  Clin Ophthalmol       Date:  2021-01-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.